Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
American Journal of Veterinary Research
|
December 29, 2015
Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs
Jeanne C Larson, Sara D Allstadt, Timothy M Fan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 31, 2016
In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog
Rebecca A Owens, Ryan J Hansen, Steven D Kahl, et al.
Integrative Cancer Therapies
|
June 13, 2013
A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma
Abby B Siegel, Rupa Narayan, Rosa Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumors
Jennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 31, 2019
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC
Triparna Sen, Carminia M Della Corte, Snezana Milutinovic, et al.
Iscience
|
July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancer
Haineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2013
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer
Anna Spreafico, John J Tentler, Todd M Pitts, et al.
British Journal of Pharmacology
|
February 13, 2023
Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure
Petra Verdino, Stacey L Lee, Fariba N Cooper, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
American Journal of Veterinary Research
|
December 29, 2015
Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs
Jeanne C Larson, Sara D Allstadt, Timothy M Fan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 31, 2016
In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog
Rebecca A Owens, Ryan J Hansen, Steven D Kahl, et al.
Integrative Cancer Therapies
|
June 13, 2013
A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma
Abby B Siegel, Rupa Narayan, Rosa Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2010
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumors
Jennifer R Diamond, Bruno R Bastos, Ryan J Hansen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 31, 2019
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC
Triparna Sen, Carminia M Della Corte, Snezana Milutinovic, et al.
Iscience
|
July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancer
Haineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2013
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer
Anna Spreafico, John J Tentler, Todd M Pitts, et al.
British Journal of Pharmacology
|
February 13, 2023
Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure
Petra Verdino, Stacey L Lee, Fariba N Cooper, et al.
Page
of 5